Interleukin 15 in murine models of colitis

Anat Rec (Hoboken). 2023 May;306(5):1111-1130. doi: 10.1002/ar.25044. Epub 2022 Jul 28.

Abstract

Inflammatory bowel diseases (IBDs) are characterized by abnormal, non-antigen specific chronic inflammation of unknown etiology. Genome-wide association studies show that many IBD genetic susceptibility loci map to immune function genes and compelling evidence indicate that environmental factors play a critical role in IBD pathogenesis. Clinical and experimental evidence implicate the pro-inflammatory cytokine IL-15 in the pathogenesis of IBD. IL-15 and IL-15α expression is increased in the inflamed mucosa of IBD patients. IL-15 contributes to the maintenance of different cell subsets in the intestinal mucosa. However, very few studies have addressed the role of IL-15 in pre-clinical models of colitis. In this study, we use three well-characterized models of experimental colitis to determine the contribution of IL-15 to pathological intestinal inflammation.

Keywords: IL-15; Salmonella; colitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colitis* / genetics
  • Colitis* / metabolism
  • Colitis* / pathology
  • Disease Models, Animal
  • Genome-Wide Association Study
  • Humans
  • Inflammation / metabolism
  • Inflammatory Bowel Diseases* / genetics
  • Inflammatory Bowel Diseases* / metabolism
  • Interleukin-15 / genetics
  • Interleukin-15 / metabolism
  • Intestinal Mucosa
  • Mice

Substances

  • Interleukin-15